Clinical Trial Update: Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the diagnostic performance of GEH300079 (68Ga) PET/CT for detecting pancreatic cancer in patients with colorectal, gastric, ovarian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• GEH300079 (68Ga) injection

Snippet

Sponsor: GE Healthcare | Conditions: Colorectal Cancer, Gastric Cancers | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING